Psychotic Disorders
📧 Sign up to get email alerts when something new happens for Psychotic Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone [NA]
This entry describes a clinical trial evaluating the efficacy and safety of a long-acting risperidone microsphere formulation in schizophren…
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting [Phase 4]
A Phase 4 clinical trial update examining how second-generation antipsychotics are used, and their effects and side effects, in real-world p…
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia [Phase 4]
A Phase 4 study compared Risperdal Consta (risperidone long-acting injectable) to Abilify (aripiprazole) over two years in patients with sch…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment [Phase 1]
A completed Phase 1 clinical trial comparing specialized treatment versus unspecified treatment for individuals with dual diagnosis of psych…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms [NA]
A completed Northwell Health trial evaluated a combination of an antidepressant and an antipsychotic for attenuated positive and negative sy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-08-24FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, a generic antipsychotic.
-
FDA approval · 2009-07-21FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Fluphenazine hydrochloride from Fresenius Kabi USA, LLC, confirming/expanding its generic pr…
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis [Phase 2]
A Phase 2 pilot study evaluating a modified cognitive behavioral therapy approach for adolescents with early onset psychosis.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: The Effects of Risperidone and Olanzapine on Thinking [Phase 4]
Phase 4 clinical trial update assessing the effects of risperidone and olanzapine on thinking/cognition in people with schizophrenia or psyc…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Pharmacy Interventions to Improve Chronic Disease Medication Refill [Phase 3]
Phase 3 clinical trial evaluating pharmacy interventions to improve chronic disease medication refills has completed.
-
FDA approval · 2008-11-25FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., confirming an additional approval for this gener…
-
FDA approval · 2008-11-25FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for HALOPERIDOL (generic) from PAI Holdings, LLC dba PAI Pharma under ANDA073037.
-
CLINICAL_TRIALS research · 2008-09-16Clinical Trial Update: DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics
A clinical trial update about using DNA diagnostics to minimize metabolic side-effects of antipsychotics in psychoses.
-
CLINICAL_TRIALS trial_result · 2008-07-25Clinical Trial Update: A Clinical Trial on the Antipsychotic Properties of Cannabidiol [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the antipsychotic properties of cannabidiol in schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone [NA]
Pfizer-sponsored trial evaluating the differential sensitivity of two spatial working memory tests in individuals with schizophrenia treated…
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine [Phase 4]
Phase 4 clinical trial evaluating duloxetine for major depressive episodes occurring during psychotic disorders has completed, assessing its…
-
FDA approval · 2008-05-29FDA Approved: HALOPERIDOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for HALOPERIDOL LACTATE from Hikma Pharmaceuticals USA Inc., under the ANDA framework.
-
FDA approval · 2008-05-15FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for COMPRO (prochlorperazine) submitted by Padagis US LLC. This action updates the product’s approva…
-
CLINICAL_TRIALS trial_result · 2008-03-31Clinical Trial Update: Safety Study of ORG 34517 for Major Depression With Psychotic Features [Phase 2]
A Phase 2 safety study evaluating ORG 34517 for major depressive disorder with psychotic features has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: New Drugs in the Treatment of Mood Disorders [Phase 2]
Phase 2 clinical trial update reporting completion of trials investigating new drugs for mood disorders.
-
CLINICAL_TRIALS research · 2008-03-03Clinical Trial Update: Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission
Clinical trial update reporting the completion of a study that compares measured plasma drug levels to expected concentrations in psychiatri…
-
FDA approval · 2007-11-29FDA Approved: HALOPERIDOL — Original Application (Zydus Lifesciences Limited)
FDA approved HALOPERIDOL from Zydus Lifesciences Limited under an Original Application (ANDA), providing a generic version of haloperidol. T…
-
CLINICAL_TRIALS research · 2007-10-10Clinical Trial Update: Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
This clinical trial update discusses evaluating aripiprazole for improving cognitive function in adolescents and young adults with psychotic…
-
CLINICAL_TRIALS research · 2007-04-20Clinical Trial Update: Dutch Prediction of Psychosis Study
Clinical trial update on the Dutch Prediction of Psychosis Study; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2007-04-03Clinical Trial Update: Rapid Tranquillization Trial: TREC-India II [Phase 3]
Phase 3 rapid tranquilization trial (TREC-India II) in psychotic disorders with aggression has completed. The status shown is COMPLETED.